《半日總結》恆指跌198點 濠賭及車股下滑 航運股逆升
港股早市隨內地股市偏軟,恆指低開108點,初段倒升8點見16,923點後再度下跌,中午前曾跌223點一度低見16,691點,半日跌198點或1.18%,報16,715點;國指跌84點或1.47%,報5,672點;恆生科技指數跌86點或2.59%,報3,249點。大市半日成交總額411.11億元,滬、深港通南下交易半日分別淨流入11.75億及11.24億元人民幣。
《澳廣視》報道指雲頂賭牌標書獲無條件接納,濠賭股銀娛(00027.HK)跌1.3%,澳博(00880.HK)、金沙中國(01928.HK)及新濠國際(00200.HK)各跌2.6%至3.1%,永利澳門(01128.HK)及美高梅中國(02282.HK)各跌4.1%及3.8%。
科技股下跌,騰訊(00700.HK)跌2.5%報248元,阿里巴巴(09988.HK)跌2.7%報73.95元,小米(01810.HK)跌0.4%報9.1元,美團(03690.HK)及京東(09618.HK)各跌3.6%及3.9%,網易(09999.HK)遭大和下調目標價,股價跌2.9%,此外,快手(01024.HK)跌5.2%,嗶哩嗶哩(09626.HK)、京東健康(06618.HK)及明源雲(00909.HK)各跌逾4%。市場關注蘋果(AAPL.US)削減iPhone 14 Plus產量,手機部件股舜宇(02382.HK)跌2.6%報76.25元。
汽車股回吐,小鵬(09868.HK)及蔚來(09866.HK)各跌8.2%及5.3%,吉利(00175.HK)跌3%。早前發盈喜的比亞迪(01211.HK)回吐1.6%報201.8元。醫藥股藥明生物(02269.HK)及翰森製藥(03692.HK)各跌5.5%及2.4%。醫藥股藥明生物(02269.HK)、康希諾(06185.HK)及百濟神州(06160.HK)各跌4.2%及5.5%。
消費股方面,李寧(02331.HK)續受新品事件困擾,股價跌4.6%報54元。泡泡瑪特(09992.HK)跌7.1%,阿里影業(01060.HK)及海爾智家(06690.HK)各跌5.9%及5.1%。
航運股隨內地A股同業上揚,東方海外(00316.HK)及太平洋航運(02343.HK)各升2.6%及3.1%,中遠海能(01138.HK)升11.3%。
其他藍籌方面,港交所(00388.HK)中午公布季績,績前跌0.5%報256.6元,匯控(00005.HK)跌1.8%報41.45元,友邦(01299.HK)升0.7%報68.85元。長和系上升,長實集團(01113.HK)及電能(00006.HK)各升逾2%,長江基建(01038.HK)升4.1%。此外,新世界(00017.HK)跌4%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.